x
Filter:
Filters applied
- Editor
- Chapron, CharlesRemove Chapron, Charles filter
Publication Date
Please choose a date range between 2014 and 2022.
Author
- Abdennebi, Inès1
- Asselain, Bernard1
- Berkach, Clémentine1
- Bobrie, Angelique1
- Coussy, Florence1
- Coutant, Charles1
- Decanter, Christine1
- Delrieu, Lidia1
- Dumas, Elise1
- Espie, Marc1
- Fumoleau, Pierre1
- Gayet, Vanessa1
- Giacchetti, Sylvie1
- Guerin, Julien1
- Hamy, Anne-Sophie1
- Houdre, Doriane1
- Jacot, William1
- Jouannaud, Christelle1
- Khallouch, Sarah1
- Laas, Enora1
- Labrosse, Julie1
- Laot, Lucie1
- Lemoine, Amélie1
- Mailliez, Audrey1
Editor's Choice
2 Results
- Article
Pregnancy, fertility concerns and fertility preservation procedures in a national study of French breast cancer survivors
Reproductive BioMedicine OnlineVol. 44Issue 6p1031–1044Published online: January 18, 2022- Manon Mangiardi-Veltin
- Clara Sebbag
- Christine Rousset-Jablonski
- Isabelle Ray-Coquard
- Clémentine Berkach
- Lucie Laot
- and others
Cited in Scopus: 3What are the real-life oncofertility practices in young women diagnosed with breast cancer? - CommentaryOpen Access
Dual ovarian stimulation is a new viable option for enhancing the oocyte yield when the time for assisted reproductive technnology is limited
Reproductive BioMedicine OnlineVol. 29Issue 6p659–661Published online: September 5, 2014- Rebecca Moffat
- Paul Pirtea
- Vanessa Gayet
- Jean Philippe Wolf
- Charles Chapron
- Dominique de Ziegler
Cited in Scopus: 34Ovarian stimulation improves assisted reproductive technology outcome by increasing the number of oocytes available for insemination and in-vitro handling. A recent Duplex protocol features a dual stimulation, with the second stimulation started immediately after the first oocyte retrieval. Remarkably, the Duplex protocol is unexpectadly well tolerated by women and provides twice as many oocytes and embryos as a regular antagonist protocol in less than 30 days.